Pharmaceutical companies loved Trump’s drug pricing speech, and that tells you all you need to know. Despite his promises, Trump has not taken on the pharmaceutical industry or done anything significant to lower drug costs — and experts doubt he will.

Trump’s drug plan goes easy on Big Pharma, which is not surprising after he gave them massive tax giveaways and appointed a former CEO as his HHS secretary.

Axios: “Trump's plan for drug costs goes easy on Big Pharma”

Washington Examiner: “Big Pharma largely unscathed by Trump’s drug-price crackdown”

STAT News: “Trump denounces ‘middlemen,’ largely spares pharma in drug pricing speech”

Despite Trump’s promise to bring Big Pharma to justice, drug companies loved his speech as their stocks soared.

Vox: “Drug company stocks really liked Friday’s Trump speech on drug prices”

STAT News: “Trump promised to bring pharma to justice. His speech sent drug stocks soaring”

MarketWatch: “President Trump’s big drug price speech boosts pharma stocks”

Trump’s drug plan does not live up to his promises, and experts doubt it will lower drug prices.

BuzzFeed: “Trump Is Promising To Lower Drug Prices, But Experts Doubt It Will Happen”

Los Angeles Times: “Trump promises to lower drug prices, but his blueprint is less sweeping than his campaign rhetoric”